BS powder effect on the mortality rate of patients with covid-19
- Conditions
- Covid-19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20230116057135N2
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Patients over 20 years old
Corona patients based on clinical symptoms, Computerized Tomography (CT) scan and laboratory tests such as Complete Blood Count (CBC), Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP), Creatine Phosphokinase (CPK), Lactate Dehydrogenase (LDH), D-Dimer and finally Polymerase Chain Reaction (PCR) confirmation test for the presence of the infectious agent.
The patient's withdrawal from the study
Patients with any other chronic disease such as diabetes, cardiovascular disease, etc.
Patients who have received supplements of vitamin D, zinc, B vitamins and other micronutrients in the last month.
Pregnant and lactating mothers
Use of corticosteroids and immunosuppressive drugs
Observing any drug sensitivity (especially digestive sensitivity to gluten) as determined by the attending physician
Deterioration of the patient's clinical symptoms due to the consumption of NBS powder, as determined by the attending physician
Patient's death during common and selective treatments (in case of death, the patient's information is fully recorded and laboratory tests are performed along with other samples to determine the possible effect of the drug on the patient's death)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method